Crossmark

Evaluation of potential drug-drug interactions in the neonatal intensive care unit with two different decision support software: a retrospective study

Crossref DOI link: https://doi.org/10.1186/s12887-025-06171-w

Published Online: 2025-10-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

AYHAN, Yunus Emre https://orcid.org/0000-0001-6093-0849
TUTAK, Ercan https://orcid.org/0000-0002-5076-8400
ÖZDEMİR, Burak https://orcid.org/0009-0003-3794-2309
License Information

Text and Data Mining valid from 2025-10-03

Version of Record valid from 2025-10-03
More Information

Article History

Received: 28 November 2024

Accepted: 8 September 2025

First Online: 3 October 2025

Declarations

:

: The study received ethical approval from the Clinical Research Ethics Committee (Decision No:82/24.04.2024). The study received ethics committee approval from Istanbul Prof. Dr. Cemil Taşcıoğlu City Hospital, and the Non-Interventional Clinical Research Ethics Committee - Forms - Retrospective Research Application Forms do not include an informed consent form (https://cemiltascioglush.saglik.gov.tr/TR-1048403/formlar.html, Access date: 02.12.2024). Therefore, no informed consent was obtained from the parents or legal guardians of any participants under the age of 16. All procedures adhered to the ethical standards of the University of Siena and the principles of the 1964 Helsinki Declaration and its later amendments.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below